Chairman of the board of directors in Yunnan peak inspection guidance work
Release time:
2022-07-03
News from our newspaper # February 19 , Chairman Jiang Xiaomeng of the Group Company went to Yunnan Jianfeng Cement Company to inspect the work and put forward guidance on the current production and operation of Yunnan Jianfeng.
In Yunnan Peak, Jiang Xiaomeng went to the production workshop and mine to inspect and guide the production, technical transformation and mine management.
At the Yunnan Peak Management Staff Meeting held later, Jiang Xiaomeng made a key understanding and analysis of cost and sales. According to Yunnan Jianfeng's operating costs, production costs, and market sales since this year, and compared with the same period last year, Jiang Xiaomeng pointed out that there are many reasons for the current severe economic situation, but overall, governments at all levels are doing everything possible to recover the economy, and the cement industry is also actively working hard to organize "self-help". Yunnan Jianfeng must strengthen its confidence and prepare for the future market recovery. To this end, he put forward requirements for Yunnan Peak from three aspects: do everything possible to reduce costs in production management, start from the raw material procurement link to grasp the cost control of the whole process, start from the development of good working habits to improve employees' awareness of consumption reduction, and through management Innovation and technological transformation continuously reduce management costs and machine material consumption, improve waste heat power generation capacity and save energy consumption; in terms of market sales, we must go all out to improve the overall "effective sales", improve profit margins by market segmentation, reasonable adjustment of product ratios, and strengthening collaboration with downstream companies; in terms of team capacity improvement, we must persist in learning, expand our horizons, and always pay attention to and learn from the experience of advanced companies in the same industry to improve their participation in the market The ability to compete.
During his stay in Pu 'er, Jiang Xiaomeng also visited relevant government departments and heads of the Federation of Industry and Commerce in Pu 'er City and Simao District, thanking local governments at all levels and all sectors of society for their concern and support for Yunnan Jianfeng. Attended the meeting of the Industrial Building Materials Association, analyzed the current market trend with the heads of local peer enterprises, and discussed topics such as breaking through the dilemma and promoting the innovation and development of Pu 'er building materials industry. (Wang Yingliang Shang Yongzhen)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page